Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000401:mortality; D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000401:mortality; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use*; D004341:Drug Evaluation; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004376:Galactitol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D010984:Platinum / Q000627:therapeutic use*; D013402:Sugar Alcohols / Q000031:analogs & derivatives*
D013402:Sugar Alcohols; D004376:Galactitol; D010984:Platinum; D004317:Doxorubicin; D003520:Cyclophosphamide